Psychosocial Risk Factors for Alzheimer's Disease in Patients with Down Syndrome and Their Association with Brain Changes: A Narrative Review
- PMID: 35596914
- PMCID: PMC9338203
- DOI: 10.1007/s40120-022-00361-9
Psychosocial Risk Factors for Alzheimer's Disease in Patients with Down Syndrome and Their Association with Brain Changes: A Narrative Review
Abstract
Several recent epidemiological studies attempted to identify risk factors for Alzheimer's disease. Age, family history, genetic factors (APOE genotype, trisomy 21), physical activity, and a low level of schooling are significant risk factors. In this review, we summarize the known psychosocial risk factors for the development of Alzheimer's disease in patients with Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. We completed a comprehensive review of the literature on PubMed, Google Scholar, and Web of Science about psychosocial risk factors for Alzheimer's disease, for Alzheimer's disease in Down syndrome, and Alzheimer's disease in Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. Alzheimer's disease causes early pathological changes in individuals with Down syndrome, especially in the hippocampus and corpus callosum. People with Down syndrome living with dementia showed reduced volumes of brain areas affected by Alzheimer's disease as the hippocampus and corpus callosum in association with cognitive decline. These changes occur with increasing age, and the presence or absence of psychosocial risk factors impacts the degree of cognitive function. Correlating Alzheimer's disease biomarkers in Down syndrome and cognitive function scores while considering the effect of psychosocial risk factors helps us identify the mechanisms leading to Alzheimer's disease at an early age. Also, this approach enables us to create more sensitive and relevant clinical, memory, and reasoning assessments for people with Down syndrome.
Keywords: Alzheimer’s disease; Corpus callosum; Dementia; Down syndrome; Hippocampus; Psychosocial risk factors.
© 2022. The Author(s).
Similar articles
-
Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.Reprod Health. 2021 Jul 26;18(1):156. doi: 10.1186/s12978-021-01203-x. Reprod Health. 2021. PMID: 34311759 Free PMC article. Review.
-
Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.Am J Psychiatry. 2002 Jan;159(1):74-81. doi: 10.1176/appi.ajp.159.1.74. Am J Psychiatry. 2002. PMID: 11772693
-
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.Am J Psychiatry. 2003 Oct;160(10):1870-8. doi: 10.1176/appi.ajp.160.10.1870. Am J Psychiatry. 2003. PMID: 14514503
-
A longitudinal study of brain anatomy changes preceding dementia in Down syndrome.Neuroimage Clin. 2018 Jan 28;18:160-166. doi: 10.1016/j.nicl.2018.01.024. eCollection 2018. Neuroimage Clin. 2018. PMID: 29868444 Free PMC article.
-
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome.Eur J Pharmacol. 2017 Dec 15;817:7-19. doi: 10.1016/j.ejphar.2017.10.004. Epub 2017 Oct 5. Eur J Pharmacol. 2017. PMID: 28987272 Review.
Cited by
-
Quality of life in adults with Down syndrome: A mixed methods systematic review.PLoS One. 2023 May 1;18(5):e0280014. doi: 10.1371/journal.pone.0280014. eCollection 2023. PLoS One. 2023. PMID: 37126503 Free PMC article.
-
Correlating MRI-based brain volumetry and cognitive assessment in people with Down syndrome.Brain Behav. 2023 Oct;13(10):e3186. doi: 10.1002/brb3.3186. Epub 2023 Jul 26. Brain Behav. 2023. PMID: 37496380 Free PMC article.
-
Factors Associated With Alzheimer's Dementia Diagnosis and Survival in Down Syndrome.J Intellect Disabil Res. 2025 Jun;69(6):489-501. doi: 10.1111/jir.13230. Epub 2025 Mar 12. J Intellect Disabil Res. 2025. PMID: 40077827 Free PMC article.
-
Going beyond established model systems of Alzheimer's disease: companion animals provide novel insights into the neurobiology of aging.Commun Biol. 2023 Jun 21;6(1):655. doi: 10.1038/s42003-023-05034-3. Commun Biol. 2023. PMID: 37344566 Free PMC article. Review.
-
Stem cell-based therapeutic strategies for down syndrome and Alzheimer's disease.Stem Cell Res Ther. 2025 Aug 5;16(1):420. doi: 10.1186/s13287-025-04556-3. Stem Cell Res Ther. 2025. PMID: 40760500 Free PMC article. Review.
References
-
- Akhtar F, Bokhari SRA. Down syndrome. Treasure Island: StatPearls; 2021.
-
- McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263–269. doi: 10.1016/j.jalz.2011.03.005. - DOI - PMC - PubMed
-
- Holland A, Reinmuth O, editors. Aphasia or dementia: the cautionary tale of Dr. JJ. Seminars in speech and language. 1998. 10.1055/s-2008-1064034. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous